iconstar paper   Hepatitis C Articles (HCV)  
Back grey arrow rt.gif
 
 
GP perceptions of liver disease; HIV & Fatty Liver/NASH
 
NASH Diagnosis and Management in General Practice
 
  Download the PDF here
 
EACS: Non-Alcoholic Fatty Liver Disease is a significant predictor of cardiovascular risk in HIV-mono-infected patients (12/04/19)
 
A gathering storm: HIV infection and nonalcoholic fatty liver disease in low and middle-income countries
- (05/24/19).....HIV-associated risk factors for NAFLD are related to ART and lipodystrophy.......Reported prevalence of NAFLD and NASH in HIV ranged from 26-65 and 31-72%, respectively.....Approximately 25-30% of HIV-negative individuals with NAFLD develop NASH [8]. In HIV-positive individuals, however, the severity both at initial presentation and that of progression is higher [30]. Although there are limited data available on histopathological correlation, in a cohort of HIV-positive individuals (91% on ART) with biopsy-proven NAFLD, the prevalence of NASH was 65% and the majority had fibrosis
 
EACS: Fibrosis, Steatosis, and NAFLD Boost Odds of Frailty in HIV Group (11/13/19)
 
Tesamorelin, liver fat, and NAFLD in the setting of HIV - Comment / Tesamorelin Prevented Progression to Liver Fibrosis in NIH Study - (10/25/19)......In people living with HIV on ART, the prevalence of NAFLD is higher (26-65%)3 and they can have more severe clinical and biochemical manifestations and a faster rate of liver fibrosis progression.4
 
Fatty Liver in HIV+
 
Fatty Liver in HIV
 
Fatty Liver, NAFLD, NASH Definitions -
 
CROI: FATTY LIVER DISEASE: A GROWING CONCERN - (04/12/17) a plenary talk by noted fatty liver expert Rohit Loomba from UCSD
 
CROI: Changes in Liver Fibrosis and Steatosis in HIV Mono-Infected patients over 24 months - 50% have fatty liver at average age of 46 - (03/28/17)
 
CROI:LIVER STEATOSIS AND FIBROSIS IN AT-RISK EUROPEAN HIV-MONOINFECTED PATIENTS - 64% with steatosis among those who had elevated LFTs and/or metabolic syndrome and/or lipodystrophy - (03/28/17)
 
--------------------------------------------------------
 
GP perceptions of liver disease
 
NASH Diagnosis and Management in General Practice
(images are copyright to R. Pryke)
 
Rachel Pryke, MBBS MRCGP FRCP
Winyates Health Centre, United Kingdom
 
European workshop on NASH in Clinical Practice
 
webcasts, slides:
 
http://www.infectiousdiseasesonline.com/european-workshop-nash-clinical-practice-enduring-materials/
 

0115201

0115202

0115203

0115204

0115205

0115206

 
 
 
 
  iconpaperstack View Older Articles   Back to Top   www.natap.org